Ahmet Murat Aydın

Assistant Professor

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

17 h-index 94 pubs 784 cited

Research Areas

Links

ORCID Research Group

OverviewAI-generated summary

Ahmet Murat Aydın's research focuses on understanding the cellular and spatial distributions of immune cells within various cancers, and how these patterns correlate with patient outcomes. His work investigates tumor-associated macrophages (CD68+), tumor-infiltrating lymphocytes (TILs), and cancer-associated fibroblasts (CAFs) in metastatic clear cell renal cell carcinoma and penile cancer. Aydın has also explored the factors affecting TIL expansion from bladder cancer patients, suggesting potential therapeutic applications. His research extends to the fundamental origins of cancer, considering oncogenesis in the context of embryogenesis. Additionally, he has examined treatment strategies, including comparative analyses of neoadjuvant chemotherapy for muscle-invasive bladder cancer and the integration of artificial intelligence with MRI for prostate cancer detection.

Aydın has published 95 papers and has an h-index of 17, with 774 citations. He collaborates with several researchers at the University of Arkansas for Medical Sciences, including Neriman Gökden (8 shared publications), Timothy Langford (4 shared publications), Sunny Singh (3 shared publications), and Jim Zhongning Chen (2 shared publications). His most recent publication is from 2025, indicating recent activity in his field.

Metrics

h-index: 17
Publications: 94
Citations: 784

Selected Publications

A call for raising public awareness and improving outcomes of penile cancer (2025)

DOI OpenAlex
External Validation of an Artificial Intelligence Algorithm Using Biparametric MRI and Its Simulated Integration with Conventional PI-RADS for Prostate Cancer Detection (2025)

5 citations DOI OpenAlex
Minimally Invasive Management of Inguinal Lymph Nodes in Penile Cancer: Recent Progress and Remaining Challenges (2024)

3 citations DOI OpenAlex
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer (2024)

2 citations DOI OpenAlex
Abstract A020: An early determination of patients eligibility for a bladder cancer immunotherapy using a data science approach (2024)

DOI OpenAlex
Identification of a panel of microRNA biomarkers for the management of patients with refractory germ cell tumor of the testis. (2024)

1 citation DOI OpenAlex
Giant left pheochromocytoma with vascular anomalies and pelvic horseshoe kidney: a case report (2023)

2 citations DOI OpenAlex
Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care (2023)

1 citation DOI OpenAlex
Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy (2023)

2 citations DOI OpenAlex
Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care (2023)

6 citations DOI OpenAlex
Abstract B015: Racial differences in epigenetic aging and its impact on expression of T-cell inhibitory receptors (2023)

DOI OpenAlex